Understanding Parkinson's Disease: A Comprehensive Overview for Healthcare Professionals
OthersPage Navigation
Introduction
As healthcare professionals, we often encounter patients with neurodegenerative disorders, among which Parkinson's disease (PD) is prevalent.
Pathophysiology
PD is a chronic, progressive disorder, primarily affecting the dopaminergic neurons in the substantia nigra of the brain. The resultant dopamine deficiency leads to motor symptoms such as tremors, rigidity, and bradykinesia.
Clinical Presentation
Patients typically present with asymmetric resting tremor, bradykinesia, and rigidity. Non-motor symptoms like depression, cognitive impairment, and autonomic dysfunction may also be present.
Management
Treatment aims to control symptoms and improve quality of life. Pharmacotherapy, including levodopa and dopamine agonists, is the mainstay. Deep brain stimulation may be considered in advanced cases.
Conclusion
Understanding PD, its pathophysiology, clinical presentation, and management options is crucial for optimal patient care. Ongoing research promises more effective therapeutic strategies in the future.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge